98%
921
2 minutes
20
The Cortisol Awakening Response (CAR) is the change in cortisol concentrations within 30-40 minutes after waking from sleep and is frequently used in stress research. Since a positive CAR is expected, we hypothesized that negative values could be associated to an underlying health condition (reflected in hematological parameters) or to environmental exposures such as lead (Pb), which has neuroendocrine effects including altered cortisol diurnal rhythms. Our aim was to analyze the prevalence of negative CAR values and their association with hematological parameters and blood Pb (BPb) levels in pregnant women (n = 900). Cortisol was measured by luminescence immunoassay in two-day saliva samples. CAR was estimated as the difference between the first (time of awakening) and second (45 min after) cortisol concentrations for each collection day and was operationalized as: both days positive (CAR-PP, 23 %), either day with a negative (CAR-NP/PN, 40 %), and both negative (CAR-NN, 37 %). A complete blood count was done using a coulter hematology analyzer. BPb was analyzed by inductively coupled plasma-mass spectrometry. Associations between hematological variables and CAR groups were analyzed using adjusted multinomial logistic regression models. Probabilities were estimated to assess the influence of BPb and hematological variables between CAR groups. The median (25th, 75th) CAR for the first collection day was -2.76 nmol/L (-16.55, 14.62) and -4.14 nmol/L (-17.66, 13.24) for the second day. Women with higher concentrations of leukocytes, eosinophils, basophils, and BPb were more likely to belong to CAR-NN or CAR-NP/PN groups. Compared to women with CAR-PP, those with CAR-NP/PN and CAR-NN had inverse associations for leukocyte levels and higher BPb concentrations. We conclude that negative CAR values could be an indicator of an underlying health condition or associated with environmental exposures such as Pb. Research should consider a thorough assessment of negative CAR values before excluding them from analyses.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12019860 | PMC |
http://dx.doi.org/10.1016/j.psyneuen.2025.107417 | DOI Listing |
Curr HIV Res
September 2025
Department of Hematology-Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China.
HIV-associated lymphoma (HAL) is an aggressive malignancy directly linked to HIV infection and accounts for more than 30% of cancer-related deaths in people living with HIV (PLWH). HAL subtypes, including diffuse large B-cell lymphoma (DLBCL), Burkitt lymphoma (BL), primary effusion lymphoma (PEL), and plasmablastic lymphoma (PBL), exhibit five to ten times higher incidence rates and distinct molecular profiles compared to HIV-negative lympho-mas. Pathogenesis involves HIV-driven CD4+ T-cell depletion, chronic B-cell activation, and on-cogenic viral coinfection.
View Article and Find Full Text PDFFront Oncol
August 2025
Division of Hematology, Department of Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
Extramedullary relapse of acute lymphoblastic leukemia (ALL) is usually associated with poor prognosis. Chimeric antigen receptor T cell (CAR-T cell) therapy followed by allogeneic hematopoietic stem cell transplantation is beneficial for relapsed/refractory (r/r) B cell acute lymphoblastic leukemia (B-ALL). Here, we report a B-ALL patient with extramedullary relapse involving several organs, including multiple lymph nodes and the breast, kidney, uterus and pancreas.
View Article and Find Full Text PDFACS Nano
September 2025
Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing 400044, China.
Despite the success of chimeric antigen receptor-T (CAR-T) in hematological malignancies, challenges persist, including limited efficacy in solid tumors, on-off tumor toxicity, and CAR-T cell persistence. Cellular mechanics profoundly influence cell behavior and function, yet the biophysical aspects of CAR-T cells remain underexplored. Here, we investigate various CAR molecules incorporating CD19 or CD123 recognition domains.
View Article and Find Full Text PDFJ Drug Target
September 2025
Department of Pharmaceutics, Division of Pharmaceutical Sciences, College of Pharmacy, Arab Academy for Science, Technology and Maritime Transport, Alexandria, P.O. Box 1029, Egypt.
Rheumatoid arthritis (RA) is a chronic autoimmune disease that causes joint inflammation, cartilage deterioration, and oxidative stress. The study developed transdermal RA treatment with L-carnosine (CAR)-loaded chondroitin sulfate (CHS) functionalized proposomes. CHS-functionalized proposomes measured 285 ± 0.
View Article and Find Full Text PDFJ Immunother Cancer
September 2025
The Comprehensive Breast Care Center, Xi'an Jiaotong University Second Affiliated Hospital, Xi'an, Shaanxi, China
Background: Triple-negative breast cancer (TNBC) represents a subtype of breast cancer with poorest prognosis due to limited effective targeted therapies. Chimeric antigen receptor T cell (CAR-T) therapy has shown remarkable efficacy in treating hematological cancers, but its application in TNBC requires further development. One major obstacle is the lack of suitable tumor-specific target in TNBC.
View Article and Find Full Text PDF